论文信息 - Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: Results of single arm phase IV COMACHI study - 字舞流文

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: Results of single arm phase IV COMACHI study

S. Takashima | N. Masuda | S. Ohtani | K. Ishida | T. Osako | S. Nagai | D. Shimizu | T. Asakawa | Yoshinori Ito | T. Takashima | M. Tsuneizumi | T. Nakayama | M. Yamaguchi | M. Ikeda | S. Matsumoto | Y. Komoike | M. Takahashi